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ABSTRACT 
 Cytokines and chemokines are soluble proteins that act as regulators of cellular functions throughout the body.  Cytokines and chemokines 
released in the setting of various CNS disorders appear in the CSF compartment where determination of their levels can provide insight into 
pathogenic processes such as neuroinflammation.  We utilized the Millipore HCYTOMAG 60K assay/kit/system to perform multiplex profiling of 
42 different cytokines/chemokines in the CSF of patients with a variety of distinct CNS disease processes, including infection, hemorrhage and 
neoplasia.  CNS infections included viral (Chronic Parechovirus type 3 (HPeV3), Enterovirus (EV) 68, Adenovirus, JC virus, West Nile virus), 
bacterial (Mycobacterium tuberculosis, Borrelia burgdorferi, Propionibacterium acnes, Staphylococcus epidermidis, Streptococcus sp.), fungal 
(Cryptococcus neoformans) and single celled parasite (Toxoplasma gondii).  CSF specimens negative for infectious organisms in non-
inflammatory conditions were selected as controls.  Additional non-infectious samples tested were obtained from patients with subarachnoid 
hemorrhage (SAH) and following surgery for glioblastoma. The glioblastoma samples were noteworthy in having negligible elevations in the 
cytokines/chemokines tested.  CSF from patients with SAH was elevated in only MCP-1/CCL2.  Distinct patterns of cytokine/chemokine 
expression were detected for each infectious patient population. Picornavirus infections HPeV3 and EV68 were associated with increased 
levels of the monocyte chemoattractant protein MCP-1/CCL2 when compared to non-infectious, non-inflammatory samples.  In contrast to 
chronic HPeV3 infection, EV68 encephalitis was associated with increased CSF levels of additional cytokines; CCLX1, IL-4 and IL-7. 
Adenovirus infection was associated with markedly higher levels of fractalkine in CSF when compared to any of the other non-inflammatory, 
infectious, hemorrhage or tumor cases. CSF from a Mycobacterium tuberculosis infection demonstrated increased levels of a greater variety of 
cytokines/chemokines than any of the other groups tested. Patterns of cytokine/chemokine expression in the CNS reveal characteristics of the 
host innate response that provide insight into the disease process and potential targets for therapeutic intervention. 
INTRODUCTION 
Because of its relationship to the critical structures of the central nervous system (CNS), the cerebrospinal fluid (CSF) 
compartment reflects the current state of the CNS, especially in neurological diseases. When pathogens invade the 
CNS, the inflammatory cascade hinges upon the expression of pro and anti-inflammatory chemokines and cytokines, 
which become detectable in the CSF.  Because various bacterial and viral pathogens utilize various mechanisms to 
elicit host response, the patterns of chemokine and cytokines released during these various infections are different. A 
variety of cells including monocytes/microglial cells play a role in initiating, coordinating, and regulating the innate 
response to infectious agents and other stimuli via expression of a variety of chemokines/cytokines.  
Routine laboratory testing of the CSF (cell counts, microbiology, etc.) are essential in the initial evaluation of certain 
disease processes; however, they are affected by various factors such as disease time course, organism burden, and 
test parameters. For instance, in up to 30% of cases of suspected viral meningitis/encephalitis, no definite virus is 
identified. By studying the cytokine/chemokine profiles of various infections, these patterns may be able to provide 
insight into the type of infectious agent involved in such cases.  Additionally, since many CNS infections are not 
histologically analyzed during active infections, chemokine/cytokine profiles may be the most immediate parameter 
available to gain insight into how a particular, pathogenic agent acts on the brain. CSF cytokine/chemokine analysis 
provides an incredible wealth of information which may help narrow differential diagnosis, understand disease 
pathophysiology, and—with further studies—help predict clinical course and disease outcome. 
RESULTS Chemokine/cytokine levels (pg/ml) in a variety of disease processes are presented in the table.  
          There is a general elevation of MCP-1/CCL2 levels in the cases.  
          IP-10/CXCL10 levels are higher in infectious cases.  
          MDC/CCL22  and MIP1a/CCL3 levels are more elevated in bacterial compared to viral Infections.  
VEGF The highest levels of VEGF are present in the CSF from patients with glioblastomas.  
          MDC/CCL22 levels from both picornavirus encephalitis (EV and HPeV3) cases are lower or similar to control   
           levels in CSF.  
          Several chemokines/cytokines from the HPeV3 case show no increase or less than a five          
          fold increase in levels compared to control values.    
          GRO/CXCL1, IL-6 and IL-8 levels are elevated in bacterial infections, the WNV case, and EV case. 
          MCP3/CCL7 levels are markedly elevated  in TB. 
          Elevated IL-17  levels present in Lyme and Strep may suggest a component of TH-17  immune response in  
          these infections.   
METHODS 
We utilized the Millipore HCYTOMAG 60K assay/kit/system to perform multiplex Elisa profiling of 42 different cytokines 
in the CSF of patients with a variety of CNS disease processes along with control (non-infectious, non-tumor, non-
hemorrhagic) samples.  We focused on the clinical cases with one, single disease process present. The cases 
reported include Lyme neuroborreliosis (Lyme) in  a 48 year old man, fatal mycobacterium tuberculosis meningitis (TB) 
in an immunosuppressed woman on adalimumab therapy, Streptococcus mitis meningitis (Strep) in a 73 year old man 
following repair of a lumbar pseudomeningocele, West Nile Virus encephalitis (WNV) in 33 year old man, clinically 
suspected viral encephalitis (?) in 20 year old woman, enterovirus encephalitis (EV) in 19 year old male, chronic 
human parechovirus type 3 encephalitis (HPeV3) in an 18 year old woman, two cases of glioblastoma (GBM), 
subarachnoid hemorrhage (SAH) secondary to rupture of cerebral saccular aneurysm and three controls that were 
negative for infectious organisms and had normal CSF findings.  The following cytokines reported in the table since 
demonstrated at least a five fold increase compared to controls in one of the disease processes selected for review. 
CONCLUSIONS 
1)  Cytokine/chemokine profiles are different in various CNS disease processes. 
2)  Cytokine/chemokine profiles may be useful in determining the nature of the 
inflammatory process, especially in the setting of inconclusive microbiology tests.   
3)  In the context of  a pro-inflammatory state, very low levels of MDC/CCL22 may 
represent a distinct pro-inflammatory response , possibly related to deficient anti-
inflammatory  mechanisms. 
4)  With further studies, CSF cytokine/chemokine profiles will provide more 
information, including predictions regarding  clinical course and disease outcome.  
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Chemokine
/Cytokine 
Lyme TB Strep WNV ?  EV HPeV3 GBM SAH Control ± Standard 
error 
MCP-1 2,000 10,000 4,000 790 334 51,409 6,830 4,600 3,207 683 ±94 
IP-10 10,000 27,000 2,000 40,000 23,075 10,000 3,674 416 384 447 ±82 
MDC 1,200 1,400 1,800 90 352 20 13 65 51 15 ±2.7 
MIP1a 90 140 29 7 11 13 7 8 13 1 ±0.17 
IL-6 17 6,800 41,225 320 3 2,362 3 438 66 3 ±0.62 
IL-8 600 2,600 3,700 260 45 20,000 108 5,100 157 36 ±11 
GRO 220 600 10,000 110 35 10,000 15 2,800 83 19 ±2.0 
G-CSF 40 1276 130 270 13 750 22 60 16 10 ±1.9 
sCD40L 102 89 100 16 160 28 27 25 14 7 ±1.8 
IL-1Ra 81 200 41 16 3 70 8 12 7 3 ±0.68 
VEGF 24 162 68 11 18 26 9 2400 12 4 ±1.4 
FGF-2 35 65 57 3 8 24 10 30 17 3 ±0 
IL-10 147 261 55 8 10 18 3 21 4 2 ±0.21 
RANTES 58 300 9 7 70 9 3 4 3 2 ±0.22 
IL-17 6 4 6 2 4 2 1 2 1 1 ±0.04 
IL-5 3 2 41 2 2 2 2 2 2 2 ±0.05 
MCP3 15 1,700 24 8 7 69 8 12 8 6 ±0.28 
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A. MCP-1 /CCL2  is an indicator of a pro-inflammatory response. 
B. IP-10/CXCL10 elevation suggests an infectious process. 
C. MIP1a/CCL3 may serve as a marker for active pathogen replication. 
F-H. IL-6, IL-8, and GRO/CXCL1 levels appear to be elevated in  
acute infections and may be an indicator infection activity. 
Can Cytokine/chemokine profiles provide information about  
a pro-inflammatory case of unknown etiology? 
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